Create a 30% bio-engineered liver mass for transplantation in patients with acute or acute-on-chronic liver failure.
Create bioengineered bile ducts to be used in liver transplant and congenital biliary diseases.
Create a 5% bio-engineered liver mass in order to develop “implantable liver tissue” for the treatment of inherited hepatic metabolic disorders.